Search results
Ani Pharmaceuticals executive sells over $2.3 million in company stock By Investing.com
Investing.com· 1 day agoANI Pharmaceuticals Inc. (NASDAQ:ANIP) has reported a significant transaction involving its...
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Sees Large Decline in Short Interest
ETF DAILY NEWS· 19 hours agoIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) was the target of a significant decrease in short interest in April. As of April 30th, there ...
BioMarin Pharmaceutical (NASDAQ:BMRN) Lowered to Hold at Baird R W
ETF DAILY NEWS· 19 hours agoBioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) was downgraded by investment analysts at Baird R W from a “strong-buy” rating to a “hold” rating ...
Telix Pharmaceuticals plans Nasdaq listing By Investing.com
Investing.com· 1 day agoTelix Pharmaceuticals Limited (ASX: TLX), an Australian biopharmaceutical company, has filed a...
Insider Selling: Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Insider Sells $290,817.60 in...
ETF DAILY NEWS· 20 hours agoLigand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) insider Matthew E. Korenberg sold 3,440 shares of Ligand Pharmaceuticals< ...
ANI Pharmaceuticals, Inc. Just Beat EPS By 459%: Here's What Analysts Think Will Happen Next
Simply Wall St. via Yahoo Finance· 6 days agoANI Pharmaceuticals, Inc. (NASDAQ:ANIP) just released its quarterly report and things are looking...
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Insider Buys $175,800.00 in Stock
ETF DAILY NEWS· 20 hours agoBioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) insider Helen M. Thackray acquired 30,000 shares of BioCryst Pharmaceuticals< ...
Stephens Initiates Coverage on Inovio Pharmaceuticals (NASDAQ:INO)
ETF DAILY NEWS· 20 hours agoStephens initiated coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a research note published on Tuesday morning, Marketbeat.com ...
Jefferies lifts Verrica Pharmaceuticals shares target on strong Ycanth prescription growth By...
Investing.com· 5 days agoOn Tuesday, Verrica Pharmaceuticals (NASDAQ:VRCA) shares saw its price target increased to $12.00,...
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives $19.00 Consensus Price Target from Analysts
ETF DAILY NEWS· 1 day agoShares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) have been given a consensus recommendation of “Hold” by the six brokerages that are ...